NegotiumBio
Biotechnology ResearchMassachusetts, United States2-10 Employees
NegotiumBio is a biotechnology research company based in North Andover, Massachusetts, that provides outsourcing strategy support to global pharmaceutical and biotech clients across drug modalities. Its work covers cellular and gene therapies (CAR-T, TCR, CRISPR, viral vectors, autologous and allogeneic supply chains, and stem cells), biologics such as monoclonal antibodies and proteins, and small molecules. The company helps clients qualify, choose, and manage suppliers through a systematic diligence process to mitigate risks associated with outsourced manufacturing, regardless of location. It also offers guidance for developing raw material management programs (GMP and non-GMP) and supports direct OEM or consolidation strategies enabled by digital cataloging tools and cloud-based marketplaces. NegotiumBio operates through two entities, NegotiumBio, LLC, in the United States and NegotiumBio GmbH in Basel, Switzerland. The company employs a small team of 2-10 people.